Additional studies will be required to evaluate the impact of NRF2 on cellular proteostasis as well as other ALS-associated gene mutations and the effect of NRF2 stimulation on late-stage microglia activation to prevent OS. Here, NFE2L2 is linked to amyotrophic lateral sclerosis.